(Q80786959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

inflammatory breast cancer

3 January 2020

main subject

1 reference

Ana Maria Gonzalez-Angulo

inferred from title

author

6

object named as

Ana Maria Gonzalez-Angulo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

11

Sonja E Singletary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

Aman U Buzdar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Massimo Cristofanilli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Vicente Valero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shu-Wan Kau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kristine R Broglio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nour Sneige

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Rabiul Islam

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Naoto T Ueno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Thomas A Buchholz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gabriel N Hortobagyi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1436-1444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Update on the management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Primary chemotherapy for early and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Inflammatory breast carcinoma: the sphinx of breast cancer research.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

CXCR4 regulates growth of both primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22927

7 January 2021

Identifiers

DOI

10.1002/CNCR.22927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17694554%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference